Home
Deutsch
Advanced Search
Browse by ...
Publication overview
Contact persons
Help
DOI
 |
|
Open Access Green as soon as Postprint is submitted to ZB.
Semaglutid in der Behandlung von Menschen mit Adipositas,Herzinsuffizienz mit erhaltener Ejektionsfraktion und Diabetes mellitus Typ 2.
Semaglutide in the treatment of people with obesity, heart failure with preserved ejection fraction, and type 2 diabetes mellitus.
Diabetologie, DOI: 10.1007/s11428-025-01316-y (2025)
Publication type
Article: Journal article
Document type
Editorial
ISSN (print) / ISBN
2731-7447
e-ISSN
2731-7455
Journal
Diabetologie, Die
Publisher
Springer
Publishing Place
Tiergartenstrasse 17, D-69121 Heidelberg, Germany
Non-patent literature
Publications
Reviewing status
Peer reviewed
Institute(s)
Helmholtz Institute for Metabolism, Obesity and Vascular Research (HI-MAG)
Helmholtz AI - FZJ (HAI - FZJ)
Helmholtz AI - FZJ (HAI - FZJ)